全文获取类型
收费全文 | 28482篇 |
免费 | 2545篇 |
国内免费 | 148篇 |
专业分类
耳鼻咽喉 | 300篇 |
儿科学 | 1115篇 |
妇产科学 | 589篇 |
基础医学 | 3620篇 |
口腔科学 | 459篇 |
临床医学 | 3603篇 |
内科学 | 4838篇 |
皮肤病学 | 506篇 |
神经病学 | 2808篇 |
特种医学 | 838篇 |
外国民族医学 | 1篇 |
外科学 | 3999篇 |
综合类 | 663篇 |
一般理论 | 23篇 |
预防医学 | 3432篇 |
眼科学 | 435篇 |
药学 | 2121篇 |
中国医学 | 45篇 |
肿瘤学 | 1780篇 |
出版年
2023年 | 235篇 |
2022年 | 335篇 |
2021年 | 791篇 |
2020年 | 435篇 |
2019年 | 754篇 |
2018年 | 882篇 |
2017年 | 622篇 |
2016年 | 604篇 |
2015年 | 690篇 |
2014年 | 941篇 |
2013年 | 1337篇 |
2012年 | 1899篇 |
2011年 | 1960篇 |
2010年 | 1088篇 |
2009年 | 957篇 |
2008年 | 1522篇 |
2007年 | 1573篇 |
2006年 | 1469篇 |
2005年 | 1458篇 |
2004年 | 1302篇 |
2003年 | 1235篇 |
2002年 | 1187篇 |
2001年 | 652篇 |
2000年 | 585篇 |
1999年 | 493篇 |
1998年 | 281篇 |
1997年 | 230篇 |
1996年 | 269篇 |
1995年 | 191篇 |
1994年 | 193篇 |
1993年 | 161篇 |
1992年 | 364篇 |
1991年 | 351篇 |
1990年 | 375篇 |
1989年 | 337篇 |
1988年 | 278篇 |
1987年 | 294篇 |
1986年 | 230篇 |
1985年 | 251篇 |
1984年 | 208篇 |
1983年 | 158篇 |
1982年 | 139篇 |
1981年 | 110篇 |
1980年 | 120篇 |
1979年 | 170篇 |
1978年 | 143篇 |
1977年 | 111篇 |
1976年 | 104篇 |
1974年 | 129篇 |
1973年 | 110篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
Robert W. McConkey RANP RNP MSc BSc PG Dip PG Cert Therese Kelly RANP RNP MSc PG Dip PG Cert Rachael Dalton RANP RNT RNP MSc BSc PG Dip Geraldine Rooney cANP RNP BSc PG Dip PG Cert Michelle Healy cANP BSc PG Cert Louise Murphy PhD BSc PG Dip RPN RNT Maura Dowling PhD MSc RGN RNT 《International Journal of Urological Nursing》2023,17(1):78-83
Evidence based practice is essential to advanced practice nursing, enabling the delivery of quality care and improved patient outcomes. As the name suggests, it requires healthcare decisions to be based on the best available and current evidence. Advanced practice nurses need astute critical analysis skills to appraise the evolving literature, and require research skills to lead on scientific inquiry and develop the profession. Yet, advanced practice nurses may not recognize themselves as research leaders. Participation in a journal club can promote evidence-based practice, improve clinician's critical thinking skills, and expose members to different research methodologies, however, nurses continue to face barriers to participation in these clubs. Establishing a clinical-academic partnership appears to be both mutually beneficial for clinicians and academics and is a significant enabler in the sustainability and functioning of the club through sharing expertise and experience. A supportive workplace culture is favourable to research utilization and knowledge translation. This paper outlines the role, practicalities, challenges, and benefits of setting up a hybrid urology journal and research club for advanced practice nurses in a clinical-academic partnership. 相似文献
995.
996.
Samuel M. Goldman MD MPH Freya Kamel PhD G. Webster Ross MD Sarah A. Jewell MD MPH Connie Marras MD PhD Jane A. Hoppin ScD David M. Umbach PhD Grace S. Bhudhikanok PhD Cheryl Meng MS Monica Korell MPH Kathleen Comyns MPH Robert A. Hauser MD Joseph Jankovic MD Stewart A. Factor DO Susan Bressman MD Kelly E. Lyons PhD Dale P. Sandler PhD J. William Langston MD Caroline M. Tanner MD PhD 《Movement disorders》2014,29(9):1171-1180
Increased gut permeability, inflammation, and colonic α‐synuclein pathology are present in early Parkinson's disease (PD) and have been proposed to contribute to PD pathogenesis. Peptidoglycan is a structural component of the bacterial cell wall. Peptidoglycan recognition proteins (PGRPs) maintain healthy gut microbial flora by regulating the immune response to both commensal and harmful bacteria. We tested the hypothesis that variants in genes that encode PGRPs are associated with PD risk. Participants in two independent case‐control studies were genotyped for 30 single‐nucleotide polymorphisms (SNPs) in the four PGLYRP genes. Using logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for potential confounding variables, we conducted analyses in each study, separately and pooled. One SNP failed the assay, and three had little to no variation. The ORs were similar in both study populations. In pooled analyses, three of seven PGLYRP2 SNPs (rs3813135, rs733731, rs892145), one of five PGLYRP3 SNPs (rs2987763), and six of nine PGLYRP4 SNPs (rs10888557, rs12063091, rs3006440, rs3006448, rs3006458, and rs3014864) were significantly associated with PD risk. Association was strongest for PGLYRP4 5'untranslated region (UTR) SNP rs10888557 (GG reference, CG OR 0.6 [95%CI 0.4‐0.9], CC OR 0.15 [95%CI 0.04‐0.6]; log‐additive P‐trend, 0.0004). Common variants in PGLYRP genes are associated with PD risk in two independent studies. These results require replication, but they are consistent with hypotheses of a causative role for the gut microbiota and gastrointestinal immune response in PD. © 2014 International Parkinson and Movement Disorder Society 相似文献
997.
998.
999.
James C. Iannuzzi Aaron S. Rickles Kristin N. Kelly Fergal J. Fleming James G. Dolan John R. T. Monson Katia Noyes 《Journal of gastrointestinal surgery》2014,18(1):60-68
Purpose
Extended-duration thromboprophylaxis (EDTPPX) is the practice of prescribing antithrombotic therapy for 21 days after discharge, commonly used in surgical patients who are at high risk for venothromboembolism (VTE). While guidelines recommend EDTPPX, criteria are vague due to a paucity of data. The criteria can be further informed by cost-effectiveness thresholds. This study sought to determine the VTE incidence threshold for the cost-effectiveness of EDTPPX compared to inpatient prophylaxis.Methods
A decision tree was used to compare EDTPPX for 21 days after discharge to 7 days of inpatient prophylaxis with base case assumptions based on an abdominal oncologic resection without complications in an otherwise healthy individual. Willingness to pay was set at $50,000/quality-adjusted life year (QALY). Sensitivity analyses were performed to assess uncertainty within the model, with particular interest in the threshold for cost-effectiveness based on VTE incidence.Results
EDTPPX was the dominant strategy when VTE probability exceeds 2.39 %. Given a willingness to pay threshold of $50,000/QALY, EDTPPX was the preferred strategy when VTE incidence exceeded 1.22 and 0.88 % when using brand name or generic medication costs, respectively.Conclusions
EDTPPX should be recommended whenever VTE incidence exceeds 2.39 %. When post-discharge estimated VTE risk is 0.88–2.39 %, patient preferences about self-injections and medication costs should be considered. 相似文献1000.